Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
[alpha-Galactosidase and Its Application in Blood Transfusion].

Zhongguo shi yan xue ye xue za zhi

Gao X.
PMID: 12578690
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2000 Sep;8(3):236-239.

alpha-galactosidase (alpha-Gal) belongs to exoglycosidases, which distributed widely in the nature. alpha-Gal can be classified into two types: alpha-Gal A and alpha-Gal B. In vivo, alpha-Gal A is responsible for the cleavage of terminal alpha-galactosidic linkages in glycoconjungates; alpha-Gal...

Cite
Gao X. [alpha-Galactosidase and Its Application in Blood Transfusion]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2000;8(3):236-239
Gao, X. (2000). [alpha-Galactosidase and Its Application in Blood Transfusion]. Zhongguo shi yan xue ye xue za zhi, 8(3), 236-239.
Gao, Xin. "[alpha-Galactosidase and Its Application in Blood Transfusion]." Zhongguo shi yan xue ye xue za zhi vol. 8,3 (2000): 236-239.
Gao X. [alpha-Galactosidase and Its Application in Blood Transfusion]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2000 Sep;8(3):236-239. Chinese. PMID: 12578690.
Copy Download .nbib Format: NLM
A New Case of Schindler Disease.

European journal of case reports in internal medicine

Castro RG, Pérez AMG, Curto MCR, Álvarez JC, Ferreirós AC, Cuadros AV, Bueno DM, Fernández AJC.
PMID: 31890708
Eur J Case Rep Intern Med. 2019 Oct 25;6(11):001269. doi: 10.12890/2019_001269. eCollection 2019.

Lysosomal storage disorders (LSDs) are a group of genetic disorders caused by mutations in genes encoding enzymes involved in lysosomal function. Schindler disease is an autosomal recessive, inherited LSD caused by defective or non-existent activity of the enzyme α-N-acetylgalactosaminidase...

Cite
Castro RG, Pérez AMG, Curto MCR, et al. A New Case of Schindler Disease. Eur J Case Rep Intern Med. 2019;6(11):001269doi: 10.12890/2019_001269.
Castro, R. G., Pérez, A. M. G., Curto, M. C. R., Álvarez, J. C., Ferreirós, A. C., Cuadros, A. V., Bueno, D. M., & Fernández, A. J. C. (2019). A New Case of Schindler Disease. European journal of case reports in internal medicine, 6(11), 001269. https://doi.org/10.12890/2019_001269
Castro, Ruben García, et al. "A New Case of Schindler Disease." European journal of case reports in internal medicine vol. 6,11 (2019): 001269. doi: https://doi.org/10.12890/2019_001269
Castro RG, Pérez AMG, Curto MCR, Álvarez JC, Ferreirós AC, Cuadros AV, Bueno DM, Fernández AJC. A New Case of Schindler Disease. Eur J Case Rep Intern Med. 2019 Oct 25;6(11):001269. doi: 10.12890/2019_001269. eCollection 2019. PMID: 31890708; PMCID: PMC6886627.
Copy Download .nbib Format: NLM
Purification and characterization of sea squirt alpha-N-acetylgalactosaminidase.

Journal of bioscience and bioengineering

Shigeta S, Suzuki O, Aki Y, Kawamoto S, Ono K.
PMID: 16232704
J Biosci Bioeng. 2000;89(1):84-6. doi: 10.1016/s1389-1723(00)88056-1.

Sea squirt alpha-N-acetylgalactosaminidase was purified to homogeneity. Its molecular weight was estimated to be approximately 160,000 by gel filtration and 40,000 by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing condition. The chromatographic and electrophoretic behaviors indicated that the enzyme was...

Cite
Shigeta S, Suzuki O, Aki Y, et al. Purification and characterization of sea squirt alpha-N-acetylgalactosaminidase. J Biosci Bioeng. 2000;89(1):84-6doi: 10.1016/s1389-1723(00)88056-1.
Shigeta, S., Suzuki, O., Aki, Y., Kawamoto, S., & Ono, K. (2000). Purification and characterization of sea squirt alpha-N-acetylgalactosaminidase. Journal of bioscience and bioengineering, 89(1), 84-6. https://doi.org/10.1016/s1389-1723(00)88056-1
Shigeta, S, et al. "Purification and characterization of sea squirt alpha-N-acetylgalactosaminidase." Journal of bioscience and bioengineering vol. 89,1 (2000): 84-6. doi: https://doi.org/10.1016/s1389-1723(00)88056-1
Shigeta S, Suzuki O, Aki Y, Kawamoto S, Ono K. Purification and characterization of sea squirt alpha-N-acetylgalactosaminidase. J Biosci Bioeng. 2000;89(1):84-6. doi: 10.1016/s1389-1723(00)88056-1. PMID: 16232704.
Copy Download .nbib Format: NLM
A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression.

Molecular psychiatry

Li Y, Ma C, Li W, Yang Y, Li X, Liu J, Wang J, Li S, Liu Y, Li K, Li J, Huang D, Chen R, Lv L, Li M, Luo XJ.
PMID: 33931730
Mol Psychiatry. 2021 Apr 30; doi: 10.1038/s41380-021-01125-x. Epub 2021 Apr 30.

Genome-wide association studies (GWASs) have revealed that genetic variants at the 22q13.2 risk locus were robustly associated with schizophrenia. However, the causal variants at this risk locus and their roles in schizophrenia remain elusive. Here we identify the risk...

Cite
Li Y, Ma C, Li W, et al. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021;doi: 10.1038/s41380-021-01125-x.
Li, Y., Ma, C., Li, W., Yang, Y., Li, X., Liu, J., Wang, J., Li, S., Liu, Y., Li, K., Li, J., Huang, D., Chen, R., Lv, L., Li, M., & Luo, X. J. (2021). A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Molecular psychiatry, . https://doi.org/10.1038/s41380-021-01125-x
Li, Yifan, et al. "A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression." Molecular psychiatry vol. (2021). doi: https://doi.org/10.1038/s41380-021-01125-x
Li Y, Ma C, Li W, Yang Y, Li X, Liu J, Wang J, Li S, Liu Y, Li K, Li J, Huang D, Chen R, Lv L, Li M, Luo XJ. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021 Apr 30; doi: 10.1038/s41380-021-01125-x. Epub 2021 Apr 30. PMID: 33931730.
Copy Download .nbib Format: NLM
A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression.

Molecular psychiatry

Li Y, Ma C, Li W, Yang Y, Li X, Liu J, Wang J, Li S, Liu Y, Li K, Li J, Huang D, Chen R, Lv L, Li M, Luo XJ.
PMID: 33931730
Mol Psychiatry. 2021 Nov;26(11):6896-6911. doi: 10.1038/s41380-021-01125-x. Epub 2021 Apr 30.

Genome-wide association studies (GWASs) have revealed that genetic variants at the 22q13.2 risk locus were robustly associated with schizophrenia. However, the causal variants at this risk locus and their roles in schizophrenia remain elusive. Here we identify the risk...

Cite
Li Y, Ma C, Li W, et al. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021;26(11):6896-6911doi: 10.1038/s41380-021-01125-x.
Li, Y., Ma, C., Li, W., Yang, Y., Li, X., Liu, J., Wang, J., Li, S., Liu, Y., Li, K., Li, J., Huang, D., Chen, R., Lv, L., Li, M., & Luo, X. J. (2021). A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Molecular psychiatry, 26(11), 6896-6911. https://doi.org/10.1038/s41380-021-01125-x
Li, Yifan, et al. "A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression." Molecular psychiatry vol. 26,11 (2021): 6896-6911. doi: https://doi.org/10.1038/s41380-021-01125-x
Li Y, Ma C, Li W, Yang Y, Li X, Liu J, Wang J, Li S, Liu Y, Li K, Li J, Huang D, Chen R, Lv L, Li M, Luo XJ. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021 Nov;26(11):6896-6911. doi: 10.1038/s41380-021-01125-x. Epub 2021 Apr 30. PMID: 33931730.
Copy Download .nbib Format: NLM
Further characterization of rat 26,000 prolactin as a glycoprotein with essentially o-linked carbohydrate chains.

Journal of neuroendocrinology

Bollengier F, Hooghe R, Velkeniers B, Mahler A, Vanhaelst L, Hooghe-Peters E.
PMID: 19215479
J Neuroendocrinol. 1991 Aug 01;3(4):375-81. doi: 10.1111/j.1365-2826.1991.tb00290.x.

Abstract In the rat two major molecular variants of prolactin are recorded i.e. 23,000 M(r) and glycosylated 26,000 M(r). In order to further characterize the glycosylated 26,000 rat prolactin molecular variant, rat pituitary cell lysates were digested with several...

Cite
Bollengier F, Hooghe R, Velkeniers B, et al. Further characterization of rat 26,000 prolactin as a glycoprotein with essentially o-linked carbohydrate chains. J Neuroendocrinol. 1991;3(4):375-81doi: 10.1111/j.1365-2826.1991.tb00290.x.
Bollengier, F., Hooghe, R., Velkeniers, B., Mahler, A., Vanhaelst, L., & Hooghe-Peters, E. (1991). Further characterization of rat 26,000 prolactin as a glycoprotein with essentially o-linked carbohydrate chains. Journal of neuroendocrinology, 3(4), 375-81. https://doi.org/10.1111/j.1365-2826.1991.tb00290.x
Bollengier, F, et al. "Further characterization of rat 26,000 prolactin as a glycoprotein with essentially o-linked carbohydrate chains." Journal of neuroendocrinology vol. 3,4 (1991): 375-81. doi: https://doi.org/10.1111/j.1365-2826.1991.tb00290.x
Bollengier F, Hooghe R, Velkeniers B, Mahler A, Vanhaelst L, Hooghe-Peters E. Further characterization of rat 26,000 prolactin as a glycoprotein with essentially o-linked carbohydrate chains. J Neuroendocrinol. 1991 Aug 01;3(4):375-81. doi: 10.1111/j.1365-2826.1991.tb00290.x. PMID: 19215479.
Copy Download .nbib Format: NLM
A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression.

Molecular psychiatry

Li Y, Ma C, Li W, Yang Y, Li X, Liu J, Wang J, Li S, Liu Y, Li K, Li J, Huang D, Chen R, Lv L, Li M, Luo XJ.
PMID: 33931730
Mol Psychiatry. 2021 Nov;26(11):6896-6911. doi: 10.1038/s41380-021-01125-x. Epub 2021 Apr 30.

Genome-wide association studies (GWASs) have revealed that genetic variants at the 22q13.2 risk locus were robustly associated with schizophrenia. However, the causal variants at this risk locus and their roles in schizophrenia remain elusive. Here we identify the risk...

Cite
Li Y, Ma C, Li W, et al. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021;26(11):6896-6911doi: 10.1038/s41380-021-01125-x.
Li, Y., Ma, C., Li, W., Yang, Y., Li, X., Liu, J., Wang, J., Li, S., Liu, Y., Li, K., Li, J., Huang, D., Chen, R., Lv, L., Li, M., & Luo, X. J. (2021). A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Molecular psychiatry, 26(11), 6896-6911. https://doi.org/10.1038/s41380-021-01125-x
Li, Yifan, et al. "A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression." Molecular psychiatry vol. 26,11 (2021): 6896-6911. doi: https://doi.org/10.1038/s41380-021-01125-x
Li Y, Ma C, Li W, Yang Y, Li X, Liu J, Wang J, Li S, Liu Y, Li K, Li J, Huang D, Chen R, Lv L, Li M, Luo XJ. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021 Nov;26(11):6896-6911. doi: 10.1038/s41380-021-01125-x. Epub 2021 Apr 30. PMID: 33931730.
Copy Download .nbib Format: NLM
Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Translational oncology

Yamamoto N, Suyama H, Yamamoto N.
PMID: 18633461
Transl Oncol. 2008 Jul;1(2):65-72. doi: 10.1593/tlo.08106.

Serum Gc protein (known as vitamin D(3)-binding protein) is the precursor for the principal macrophage-activating factor (MAF). The MAF precursor activity of serum Gc protein of prostate cancer patients was lost or reduced because Gc protein was deglycosylated by...

Cite
Yamamoto N, Suyama H, Yamamoto N. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Transl Oncol. 2008;1(2):65-72doi: 10.1593/tlo.08106.
Yamamoto, N., Suyama, H., & Yamamoto, N. (2008). Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Translational oncology, 1(2), 65-72. https://doi.org/10.1593/tlo.08106
Yamamoto, Nobuto, et al. "Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF." Translational oncology vol. 1,2 (2008): 65-72. doi: https://doi.org/10.1593/tlo.08106
Yamamoto N, Suyama H, Yamamoto N. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Transl Oncol. 2008 Jul;1(2):65-72. doi: 10.1593/tlo.08106. PMID: 18633461; PMCID: PMC2510818.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries